Abstract Background Hydatid cyst (HC) most commonly involves the liver or lungs, but it can affect almost any organ or tissue. In very rare cases, it occurs in the musculoskeletal
A single-center RCT with short-term surrogate endpoints (cardiac function, self-care, quality of life) showing statistically significant differences at 3 months, but limited by absence of hard clinical outcomes, modest sample size, and acknowledged need for multicenter confirmation.
A narrative review synthesizing guideline updates and registry evidence on TAVR durability and reintervention; informs clinical decision-making but lacks original comparative effectiveness data.